Sign in
4

Changes in Ownership

BRAINSTORM CELL THERAPEUTICS INC. Filed Acc 0001104659-26-064656

Options or other derivatives

  • Director acquired 225,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
HARTOUNIAN HARTOUN Director 2026-02-26 Grant or award · Stock Option (Right to Buy) +225,000 $0.70 $157,500 225,000 D: show line 1 in the form
Loading xslF345X06/tm267728-4_4seq1.xml…